�New technologies will force fundamental change in the way healthcare systems operate. Low-cost cistron sequencing and biopharmaceuticals will make personalized medicine a reality - tailoring the treatment to the patient. The spread of broadband networks makes telemedicine workable for many, and computerized patient records will transubstantiate medical inquiry. New tomography and diagnostics technologies open the door to more preventative medical specialty.
So what will it be like to be sick in 2020? Who will treat you? How will they get nonrecreational? How volition health authorities decide which new technologies are worth the money?
These ar among the pressing questions to be examined at an international gathering of research, industriousness and insurance policy experts Nov. 6, organized by UCL Advances, UCL's centre for entrepreneurship and business fundamental interaction, and the Science|Business news service. The conference volition draw on expertise from all the new engineering strands - bioinformatics, imaging, diagnostics, devices, biopharmaceuticals and more - to make a composite picture of the patient experience in 2020, and to talk about what healthcare authorities should be doing now to prepare for that day. The outcomes will admit a survey and special report summarizing the modern scenarios - plus expert recommendations for action.
The conference is a join venture between UCL Advances and Science Business Publishing Ltd., a UK-based media company focused on R&D investment and policy crossways Europe. Learn more about the conference by visiting the site here.
About Science Business
Science Business Publishing Ltd. is a London-based media company focused on R&D investment in Europe. It reports word daily online and in a weekly newsletter, and organizes events to land together public-sector researchers, corporate partners and policy makers. It was founded in 2005 by the former managing editors of the Wall Street Journal Europe and prima science journal Nature, and works with a network of 10 leading European research universities, including UCL.
Science Business
More info
